Alunbrig (brigatinib) 90 mg film-coated tablets, 30 tablets — generic (Laos) Targeted cancer therapy. Drug delivery from Europe within 4-5 days, guaranteed storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Alunbrig® is indicated as a monotherapy for the treatment of adult patients with advanced non-ligamentous lung cancer (NLCLC), positive for anaplastic lymphoma kinase (ALK), who have not previously received treatment. ALK inhibitor.

Alunbrig® as a monotherapy is indicated for the treatment of adult patients with advanced ALK-positive PCLCL who have previously been treated with crizotinib.